(Q45919592)

English

A phase IB study of ABT-751 in combination with docetaxel in patients with advanced castration-resistant prostate cancer.

scientific article published on 24 July 2009

Statements

A phase IB study of ABT-751 in combination with docetaxel in patients with advanced castration-resistant prostate cancer. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit